BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

AI Briefing

• – Phase 3 clinical data shows quality of life preserved in heavily pretreated metastatic breast cancer patients
• – BriaCell presents positive data in three clinical posters at the 2026 AACR Annual Meeting
• – Company to bring novel immunotherapies to cancer patients with unmet medical needs